Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
marketed for diabetes as Mounjaro and for weight management under trade names such as Zepbound) Tirzepatide combines GLP-1 and GIP receptor agonism and has shown the largest average weight losses of any medication to date
Let's create your personalized plan
The real transformation becomes apparent around the 8-week mark when cumulative GH elevation has built sufficient IGF-1 levels to produce visible changes
PMID 24106592
Key facts SKU: ALP-IGF Form: Lyophilised powder Presentation: Mass per vial as selected on the product page Appearance (typical): White to off-white lyophilised powder Intended laboratory context Controlled in-vitro models where IGF-axis biology is studied under institutional protocols Analytical characterisation and method development Non-clinical peptide handling and preparation workflows in laboratory settings Specifications Batch identity and purity parameters appear on the COA where stated for the lot supplied Handle as potent laboratory peptide per SDS Documentation scope may be limited to in-house or supplier release records for some lots (see notice in short description) Documentation and batch release COA and SDS are supplied with released lots within the scope described on this page
Sarah was incredibly knowledgeable and made me feel at ease
US$ 27.51
US$ 23.10
US$ 22.33
US$ 20.36
US$ 28.15
